BioTech/Drugs - Cambridge, MA, US
CEO
Contact Grigory Khimulya
Venture-backed biotechnology company engineering high-impact protein therapeutics
Gmail
Amazon CloudFront
Route 53
Google Apps
Amazon AWS
Lever